Buch, Englisch, Band 95, 336 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 617 g
Buch, Englisch, Band 95, 336 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 617 g
Reihe: International Review of Neurob
ISBN: 978-0-12-381326-8
Verlag: ACADEMIC PR INC
Volume 95 of International Review of Neurobiology focuses on Catechol-O-methyltransferase inhibition, and its clinical application in relation to Parkinson's disease. Chapters cover COMT gene and proteins, L-dopa treatment in Parkinson's disease, the latest research on COMT inhibitors and their clinical applications, as well as future prospects for their use.
Zielgruppe
Neuroscientists, neurologists, psychologists
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Naturwissenschaften Biowissenschaften Biowissenschaften Neurobiologie, Verhaltensbiologie
- Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
Weitere Infos & Material
- Introductory remarks: Catechol-O-methyltransferase inhibition: an innovative approach to enhance L-dopa therapy in Parkinson's disease with dual enzyme inhibition
Erkki Nissinen
- The catechol-O-methyltransferase gene, its regulation and polymorphisms
Elizabeth M. Tunbridge
- Distribution and functions of catechol-O-methyltransferase proteins: do recent findings change the picture?
Timo T. Myöhänen & Pekka T. Männistö
- Catechol-O-methyltransferase enzyme: Cofactor S-adenosyl-L-methionine and related mechanisms
Thomas Müller
- Biochemistry and pharmacology of catechol-O-methyltrasferase inhibitors
Erkki Nissinen and Pekka T. Männistö
- The Chemistry of Catechol-O-methyltransferase Inhibitors
David A. Learmonth, László E. Kiss and Patrício Soares-da-Silva
- Toxicology and safety of COMT inhibitors
Kristiina Haasio
- Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of the L-dopa treatment
Concepció Marin, J.A. Obeso
- Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson's disease
Seppo Kaakkola
- Catechol-O-methyltransferase and pain
Oleg Kambur & Pekka T. Männistö